ID1 and neoplasm: The recently discovered small molecule AGX51, which inhibits ID proteins by targeting them for ubiquitin-mediated proteolysis, has shown strong anti-tumor effects, good toleration and lack of acquired resistance in murine models of colorectal and lung cancer60.